Product
Pathogen-Reduced Cryoprecipitate
1 clinical trial
2 indications
Indication
HypofibrinogenemiaIndication
BleedingClinical trial
Pilot Clinical Trial of Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen (INTERCEPT Fibrinogen Complex) in Patients With Bleeding to Expedite Product Availability and Improve Outcomes in Perioperative BleedingStatus: Recruiting, Estimated PCD: 2024-03-01